Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells

28 Oct 2015

Abstract excerpt

UNLABELLED: Recent advances in the generation of cardiomyocytes (CMs) from human pluripotent stem cells (hPSCs), in conjunction with the promising outcomes from preclinical and clinical studies, have raised new hopes for cardiac cell therapy. We report the development of a scalable, robust, and integrated differentiation platform for large-scale production of hPSC-CM aggregates in a stirred suspension bioreactor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pluripotent Stem Cells Research
Share to Renal and related cancers
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26511653
DOI: 10.5966/sctm.2014-0275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem CellsPMID 26511653Read ↗

Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cellsSemantic proximity Read ↗

Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cellsSemantic proximity Read ↗

Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Semantic proximity Read ↗

Efficient and reproducible generation of human iPSC-derived cardiomyocytes using a stirred bioreactorSemantic proximity Read ↗

Bioreactor Suspension Culture: Differentiation and Production of Cardiomyocyte Spheroids From Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem CellsSemantic proximity Read ↗

A Simple, Cost-Effective but Highly Efficient System for Deriving Ventricular Cardiomyocytes from Human Pluripotent Stem CellsSemantic proximity Read ↗

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesSemantic proximity Read ↗

Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic ToolsSemantic proximity Read ↗

Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell PromiseSemantic proximity Read ↗

Xenogeneic-Free System for Biomanufacturing of Cardiomyocyte Progeny From Human Pluripotent Stem CellsSemantic proximity Read ↗

Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner cultureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.